HIV/AIDS Groups Express Concern About Potential For New Antiretroviral Advertising To ‘Scare Off’ Patients

The Wall Street Journal on Monday examined a new trend for drugmakers marketing HIV/AIDS treatments to release ads that “tak[e] aim at rival HIV drugs, hinting at side effects and other drawbacks.

More: continued here

This entry was posted on Tuesday, August 26th, 2008 at 9:08 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.